• VIMPAT Receives EU Approval for Expanded Pediatric Use
  • Pairnomix, StemoniX Develop Epilepsy Model in Search for New Anti-seizure Drugs
  • Data Lacking to Explain Why US Doctors Prefer Keppra to Treat Pediatric Epilepsy, Researchers Say
  • EU Regulators to Hold Public Hearing on Valproate Therapies’ Effect on Pregnant Women
  • MRI-Guided Laser Technique May Be Potential Surgery Treatment for Certain Epilepsy Patients, Review Says
  • Cleveland Clinic Researcher Wins $3.4 Million Grant to Develop Better Predictor of Epileptic Surgery Outcomes
  • Surgery in Older Patients with Drug-resistant Focal Epilepsy Still Effective, Study Finds
  • Ultra-Marathon Cyclist Who Is Epileptic Breaks Two World Indoor Distance Records
  • LivaNova’s VNS Therapy for Medication-Resistant Epilepsy Approved for Young Children
  • Zebinix/Aptiom Does Not Reduce Cognition in Epileptic Children, Phase 2 Clinical Trial Indicates
  • Nearly Half of Epileptics Forget to Take Their Meds at Least Once a Month, Poll Shows
  • LivaNova’s VNS Therapy Systems Approved for Use with MRI Brain Scans